CARTHERai™
CAnceR THErapy Rating Algorithm Infrastructure
Technology
Powered by advanced Artificial Intelligence
The CARTHERai™ platform automates the search for effective anti-cancer treatment with advanced AI technology through a network of algorithms. The platform creates a personalized therapy ranking for each patient complete with biological understanding of the genetic cause of the disease and different ways to access novel therapies in clinical trials.
More precisely, CARTHERai™ uses multiple levels of biomarkers selected by advanced whole genome sequencing pipeline coupled with custom AI solutions to identify the portrait of cancers, ‘SIGNATURES’ to define response to each treatment option and patient benefit.
Learn more
Pipeline
- Data integration
- Data processing
- Biomarker extraction
- Biomarker boundling – providing understanding of tumor physiology
Learn more
Our publications
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
The First Report of Biallelic Missense Mutations in the SFRP4 Gene Causing Pyle Disease in Two Siblings
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
